Literature DB >> 21735043

Linking new and old concepts: inflammation meets the Warburg phenomenon in pulmonary arterial hypertension.

Todd M Kolb1, Rachel L Damico, Paul M Hassoun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21735043     DOI： 10.1007/s00109-011-0783-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  21 in total

1.  Distinct immune profiles characterize patients with diffuse or limited systemic sclerosis.

Authors:  Francesca Ingegnoli; Daria Trabattoni; Marina Saresella; Flavio Fantini; Mario Clerici
Journal:  Clin Immunol       Date:  2003-07       Impact factor: 3.969

2.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

3.  Increased pyruvate dehydrogenase kinase activity in response to sepsis.

Authors:  T C Vary
Journal:  Am J Physiol       Date:  1991-05

Review 4.  One hundred years of research in the pathogenesis of pulmonary hypertension.

Authors:  Ari Zaiman; Iwona Fijalkowska; Paul M Hassoun; Rubin M Tuder
Journal:  Am J Respir Cell Mol Biol       Date:  2005-11       Impact factor: 6.914

5.  Changes in causes of death in systemic sclerosis, 1972-2002.

Authors:  Virginia D Steen; Thomas A Medsger
Journal:  Ann Rheum Dis       Date:  2007-02-28       Impact factor: 19.103

6.  Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels.

Authors:  Evangelos D Michelakis; M Sean McMurtry; Xi-Chen Wu; Jason R B Dyck; Rohit Moudgil; Teresa A Hopkins; Gary D Lopaschuk; Lakshmi Puttagunta; Ross Waite; Stephen L Archer
Journal:  Circulation       Date:  2002-01-15       Impact factor: 29.690

7.  Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.

Authors:  Marc Humbert; Olivier Sitbon; Ari Chaouat; Michèle Bertocchi; Gilbert Habib; Virginie Gressin; Azzedine Yaïci; Emmanuel Weitzenblum; Jean-François Cordier; François Chabot; Claire Dromer; Christophe Pison; Martine Reynaud-Gaubert; Alain Haloun; Marcel Laurent; Eric Hachulla; Vincent Cottin; Bruno Degano; Xavier Jaïs; David Montani; Rogério Souza; Gérald Simonneau
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

8.  Fatty acid oxidation and malonyl-CoA decarboxylase in the vascular remodeling of pulmonary hypertension.

Authors:  Gopinath Sutendra; Sebastien Bonnet; Gael Rochefort; Alois Haromy; Karalyn D Folmes; Gary D Lopaschuk; Jason R B Dyck; Evangelos D Michelakis
Journal:  Sci Transl Med       Date:  2010-08-11       Impact factor: 17.956

9.  Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury.

Authors:  Sarah A Pendergrass; Everett Hayes; Giuseppina Farina; Raphael Lemaire; Harrison W Farber; Michael L Whitfield; Robert Lafyatis
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

Review 10.  Inflammation, growth factors, and pulmonary vascular remodeling.

Authors:  Paul M Hassoun; Luc Mouthon; Joan A Barberà; Saadia Eddahibi; Sonia C Flores; Friedrich Grimminger; Peter Lloyd Jones; Michael L Maitland; Evangelos D Michelakis; Nicholas W Morrell; John H Newman; Marlene Rabinovitch; Ralph Schermuly; Kurt R Stenmark; Norbert F Voelkel; Jason X-J Yuan; Marc Humbert
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094
View more
  1 in total

Review 1.  Metabolic dysfunction in pulmonary hypertension: the expanding relevance of the Warburg effect.

Authors:  Katherine A Cottrill; Stephen Y Chan
Journal:  Eur J Clin Invest       Date:  2013-04-26       Impact factor: 4.686
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.